This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Serdyuk, A. P. Articles by Morton, R. E. Search for Related Content PubMed PubMed Citation Articles by Serdyuk, A. P. Articles by Morton, R. E. Related Collections Biochemistry and metabolism Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:718-726.)
© 1999 American Heart Association, Inc.

Original Contributions

Lipid Transfer Inhibitor Protein Defines the Participation of Lipoproteins in Lipid Transfer Reactions

CETP Has No Preference for Cholesteryl Esters in HDL Versus LDL

Anatole P. Serdyuk; Richard E. Morton

From the Department of Cell Biology, The Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH (A.P.S., R.E.M.); and Department of Biochemistry, National Research Center for Preventive Medicine, Moscow, Russia (A.P.S.).

Correspondence to Richard E. Morton, PhD, Dept. of Cell Biology, NC 10, The Lerner Research Institute, Cleveland Clinic Foundation, 9500 Euclid Ave., Cleveland, OH 44195. E-mail mortonr{at}cesmtp.ccf.org

Abstract—Cholesteryl ester transfer protein (CETP) catalyzes the net transfer of cholesteryl ester (CE) between lipoproteins in exchange for triglyceride (heteroexchange). It is generally held that CETP primarily associates with HDL and preferentially transfers lipids from this lipoprotein fraction. This is illustrated in normal plasma where HDL is the primary donor of the CE transferred to VLDL by CETP. However, in plasma deficient in lipid transfer inhibitor protein (LTIP) activity, HDL and LDL are equivalent donors of CE to VLDL (Arterioscler Thromb Vasc Biol. 1997;17:1716–1724). Thus, we have hypothesized that the preferential transfer of CE from HDL in normal plasma is a consequence of LTIP activity and not caused by a preferential CETP-HDL interaction. We have tested this hypothesis in lipid mass transfer assays with partially purified CETP and LTIP, and isolated lipoproteins. With a physiological mixture of lipoproteins, the preference ratio (PR, ratio of CE mass transferred from a lipoprotein to VLDL versus its CE content) for HDL and LDL in the presence of CETP alone was 1 (ie, no preference). Fourfold variations in the LDL/HDL ratio or in the levels of HDL in the assay did not result in significant preferential transfer from any lipoprotein. On addition of LTIP, the PR for HDL was increased up to 2-fold and that for LDL decreased in a concentration-dependent manner. Under all conditions where LDL and HDL levels were varied, LTIP consistently resulted in a PR >1 for CE transfer from HDL. Short-term experiments with radiolabeled lipoproteins and either partially purified or homogenous CETP confirmed these observations and further demonstrated that CETP has a strong predilection to mediate homoexchange (bidirectional transfer of the same lipid) rather than heteroexchange (CE for TG); LTIP had no effect on the selection of CE or TG by CETP or its mechanism of action. We conclude, in contrast to current opinion, that CETP has no preference for CE in HDL versus LDL, suggesting that the previously reported stable binding of CETP to HDL does not result in selective transfer from this lipoprotein. These data suggest that LTIP is responsible for the preferential transfer of CE from HDL that occurs in plasma. CETP and LTIP cooperatively determine the extent of CETP-mediated remodeling of individual lipoprotein fractions.

Key Words: cholesteryl ester transfer protein • lipid transfer inhibitor protein • lipoprotein preference • cholesteryl ester • heteroexchange

This article has been cited by other articles:

				L. K. Potter, D. L. Sprecher, M. C. Walker, and F. L. Tobin Mechanism of inhibition defines CETP activity: a mathematical model for CETP in vitro J. Lipid Res., November 1, 2009; 50(11): 2222 - 2234. [Abstract] [Full Text] [PDF]

				W. R. Lagor, R. J. Brown, S.-A. Toh, J. S. Millar, I. V. Fuki, M. de la Llera-Moya, T. Yuen, G. Rothblat, J. T. Billheimer, and D. J. Rader Overexpression of Apolipoprotein F Reduces HDL Cholesterol Levels In Vivo Arterioscler Thromb Vasc Biol, January 1, 2009; 29(1): 40 - 46. [Abstract] [Full Text] [PDF]

				Y. He, D. J. Greene, M. Kinter, and R. E. Morton Control of cholesteryl ester transfer protein activity by sequestration of lipid transfer inhibitor protein in an inactive complex J. Lipid Res., July 1, 2008; 49(7): 1529 - 1537. [Abstract] [Full Text] [PDF]

				R. E. Morton, H. M. Gnizak, D. J. Greene, K.-H. Cho, and V. M. Paromov Lipid transfer inhibitor protein (apolipoprotein F) concentration in normolipidemic and hyperlipidemic subjects J. Lipid Res., January 1, 2008; 49(1): 127 - 135. [Abstract] [Full Text] [PDF]

				R. E. Morton and D. J. Greene CETP and lipid transfer inhibitor protein are uniquely affected by the negative charge density of the lipid and protein domains of LDL J. Lipid Res., December 1, 2003; 44(12): 2287 - 2296. [Abstract] [Full Text] [PDF]

				V. M. Paromov and R. E. Morton Lipid Transfer Inhibitor Protein Defines the Participation of High Density Lipoprotein Subfractions in Lipid Transfer Reactions Mediated by Cholesterol Ester Transfer Protein (CETP) J. Biol. Chem., October 17, 2003; 278(42): 40859 - 40866. [Abstract] [Full Text] [PDF]

				R. E. Morton and D. J. Greene The surface cholesteryl ester content of donor and acceptor particles regulates CETP: a liposome-based approach to assess the substrate properties of lipoproteins J. Lipid Res., July 1, 2003; 44(7): 1364 - 1372. [Abstract] [Full Text] [PDF]

				I. Staprans, X.-M. Pan, J. H. Rapp, and K. R. Feingold Oxidized cholesterol in the diet is a source of oxidized lipoproteins in human serum J. Lipid Res., April 1, 2003; 44(4): 705 - 715. [Abstract] [Full Text] [PDF]

				J. W. Skeggs and R. E. Morton LDL and HDL enriched in triglyceride promote abnormal cholesterol transport J. Lipid Res., August 1, 2002; 43(8): 1264 - 1274. [Abstract] [Full Text] [PDF]

				S. J. Murdoch, G. Wolfbauer, H. Kennedy, S. M. Marcovina, M. C. Carr, and J. J. Albers Differences in reactivity of antibodies to active versus inactive PLTP significantly impacts PLTP measurement J. Lipid Res., February 1, 2002; 43(2): 281 - 289. [Abstract] [Full Text] [PDF]

				R. E. Morton, V. Nunes, L. Izem, and E. Quintao Markedly Elevated Lipid Transfer Inhibitor Protein in Hypercholesterolemic Subjects Is Mitigated by Plasma Triglyceride Levels Arterioscler Thromb Vasc Biol, October 1, 2001; 21(10): 1642 - 1649. [Abstract] [Full Text] [PDF]

				D. J. Greene, J. W. Skeggs, and R. E. Morton Elevated Triglyceride Content Diminishes the Capacity of High Density Lipoprotein to Deliver Cholesteryl Esters via the Scavenger Receptor Class B Type I (SR-BI) J. Biol. Chem., February 9, 2001; 276(7): 4804 - 4811. [Abstract] [Full Text] [PDF]